Jump to main content
Jump to site search

Issue 23, 2017
Previous Article Next Article

C-Reactive protein: a major inflammatory biomarker

Author affiliations

Abstract

Inflammatory biomarkers are released during tumour growth, and they are highly associated with stages of cancer progression. C-Reactive protein is one of the widely studied marker proteins, which is associated with inflammation. CRP levels have been used to predict survival in patients with different cancers. The assimilation of CRP into prognostic models for cancers improves their predictive accuracy. The analysis of changes in CRP concentration over time can allow for the prediction of tumour aggressiveness and treatment efficacy. Therefore CRP can be an important biomarker for cancer diagnosis and prognosis, and the monitoring of treatment outcomes. This critical review focuses on the role of C-reactive protein in different types of cancers and its relation to the different stages of cancer. This article also focuses on recently reported methods for the detection of CRP.

Graphical abstract: C-Reactive protein: a major inflammatory biomarker

Back to tab navigation

Publication details

The article was received on 17 Mar 2017, accepted on 16 May 2017 and first published on 17 May 2017


Article type: Critical Review
DOI: 10.1039/C7AY00711F
Citation: Anal. Methods, 2017,9, 3400-3413
  •   Request permissions

    C-Reactive protein: a major inflammatory biomarker

    M. D. Sonawane and S. B. Nimse, Anal. Methods, 2017, 9, 3400
    DOI: 10.1039/C7AY00711F

Search articles by author

Spotlight

Advertisements